##plugins.themes.academic_pro.article.sidebar##

Download
pdf
Statistic
Read Counter : 73 Download : 71

##plugins.themes.academic_pro.article.main##

Abstract

According to modern researchers, one of the most common comorbid diseases in patients with psoriatic arthritis (PsA) is cardiovascular disease (CVD). The incidence of CVD in PsA can be as high as 78%. In general, it was found that in PsA patients, coronary heart disease (CHD) and arterial hypertension (AH) occupy a special place, because they are objectively traceable markers of cardiovascular pathology (CVP) in PsA in real clinical practice.

Keywords

psoriatic arthritis arterial hypertension coronary heart disease

##plugins.themes.academic_pro.article.details##

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

How to Cite
Abdullaev Ulugbek Sayfullaevich. (2023). Evaluation Of Indicators of Instrumental Methods Of Cardiovascular Pathology Research In Patients With Psoriatic Arthritis . Texas Journal of Medical Science, 23, 57–60. https://doi.org/10.62480/tjms.2023.vol23.pp57-60
Crossref
Scopus
Google Scholar
Europe PMC

References

  1. Green A, Shaddick G, Charlton R, et al. Modifiable risk factors and the development of psoriatic arthritis in people with psoriasis. Br J Dermatol 2020; 182: 714–720.
  2. Hansson G.K. Inflammation and atherosclerosis: the end of a controversy Circulation, 136 (2017), pp. 1875-1877.
  3. Holland R., Tillett W., Korendowych E., et al.Validation of the psoriatic arthritis impact of disease (PsAID) questionnaire and its potential as a single-item outcome measure in clinical practice Ann. Rheum. Dis., 77 (2018), pp. 343-347.
  4. Husted J.A, Thavaneswaran A., Chandran V., Gladman D.D. Incremental effects of comorbidity on quality of life in patients with psoriatic arthritis. J. Rheumatol., 40 (2013), pp. 1349-1356.
  5. Neiman A.L., Shin D.B., Wang x D.B. at al. /Prevalence of cardiovascular risk factors in patients with psoriasis // J. Am. Acad. Dermatology. 2006 - P. 55 -829-834.
  6. Polachek A., Touma Z., Anderson M., Eder L. Risk of cardiovascular morbidity in patients with psoriatic arthritis: a meta-analysis of observational studies Arthritis Care Res., 69 (2017), pp. 67-74.
  7. Puig L. Cardiometabolic comorbidities in psoriasis and psoriatic arthritis. Int J Mol Sci 2018; 19: 58.